AVDL — Avadel Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $2.11bn
- $2.06bn
- $169.12m
Irish biopharma firm Avadel's Q3 revenue up 55%, but net income misses estimates
Brief: Avadel Pharmaceuticals Q3 EPS USD 0
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Mattel, Alphabet, GE Vernova
U.S. STOCKS ON THE MOVE-Healthcare Services Group, Western Alliance, Warner Bros Discovery
Avadel rises after Alkermes' $2.1 billion buyout deal
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE- Avadel Pharma, Amphenol, Applied Digital
Alkermes enters sleep medicine market with $2.1 billion Avadel deal (updated)
Avadel rises after Alkermes' $2.1 billion buyout deal
Alkermes to acquire Avadel for up to $2.1 billion
Brief: Avadel Says Court Orders 3.85% Royalty on Lumryz Sales to Jazz
Brief: Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio With Exclusive License Of Valiloxybate From XWPharma Ltd
Avadel Pharmaceuticals PLC reports results for the quarter ended June 30 - Earnings Summary
Avadel Pharma Q2 revenue up 64%, raises 2025 guidance
Avadel Pharmaceuticals PLC expected to post earnings of 3 cents a share - Earnings Preview
Brief: Avadel Pharmaceuticals To Provide A Corporate Update And Report Second Quarter 2025 Financial Results On August 7
ASL pushes for board shakeup at Avadel over handling of sleep drug rollout
Brief: Asl Strategic Value Fund Issues Open Letter To Avadel Shareholders